Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0001193125-25-314737

Francis Chris sold 441,031 shares at an average $14.57 ($6,427,085)

  • Francis Chris acquired 441,031 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Francis Chris

Table I: Non-derivative

18 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-08 Exercise or conversion : show line 1 in the form 10b5-1 +28,125 $3.14 $88,313 53,125 D
2025-12-08 Sale : show line 2 in the form 10b5-1 −28,125 $14.50 $407,813 25,000 D
2025-12-08 Exercise or conversion : show line 3 in the form 10b5-1 +107,400 $3.87 $415,638 132,400 D
2025-12-08 Sale : show line 4 in the form 10b5-1 −107,400 $14.56 $1,563,314 25,000 D
2025-12-08 Exercise or conversion : show line 5 in the form 10b5-1 +45,882 $4.75 $217,940 70,882 D
2025-12-08 Sale : show line 6 in the form 10b5-1 −45,882 $14.50 $665,289 25,000 D
2025-12-08 Exercise or conversion : show line 7 in the form 10b5-1 +9,375 $3.14 $29,438 34,375 D
2025-12-08 Sale : show line 8 in the form 10b5-1 −9,375 $15.00 $140,625 25,000 D
Open-market sales · 441,031 sh · avg $14.57 · $6,427,085

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2025-12-08 Exercise or conversion : show line 19 in the form 10b5-1 Share Option (right to buy) −75,000 9,375 D
2025-12-08 Exercise or conversion : show line 20 in the form 10b5-1 Share Option (right to buy) −125,300 161,100 D
2025-12-08 Exercise or conversion : show line 21 in the form 10b5-1 Share Option (right to buy) −168,231 76,469 D
2025-12-08 Exercise or conversion : show line 22 in the form 10b5-1 Share Option (right to buy) −50,000 0 D
2025-12-08 Exercise or conversion : show line 23 in the form 10b5-1 Share Option (right to buy) −22,500 0 D
Loading xslF345X05/ownership.xml…